LAURA BOLEN: Open Payments
NPI 1558879379 · KENDALLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 84 payments from 19 companies in 2025. Trend: 2023 $785 · 2024 $1,317 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $280 |
| ABBVIE INC. | 24 | $253 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $194 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Novo Nordisk Inc | 6 | $103 |
| Xeris Pharmaceuticals, Inc. | 5 | $79 |
| Abbott Laboratories | 3 | $69 |
| PFIZER INC. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $49 |
Products named: JARDIANCE, VRAYLAR, QULIPTA, AIRSUPRA, REXULTI, GVOKE HYPOPEN, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across IN — which companies pay providers there.
